Growth Metrics

AVITA Medical (RCEL) Operating Leases (2018 - 2025)

AVITA Medical filings provide 8 years of Operating Leases readings, the most recent being $2.1 million for Q4 2025.

  • On a quarterly basis, Operating Leases fell 24.82% to $2.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 24.82% decrease, with the full-year FY2025 number at $2.1 million, down 24.82% from a year prior.
  • Operating Leases hit $2.1 million in Q4 2025 for AVITA Medical, down from $2.3 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $3.3 million in Q2 2024 to a low of $306000.0 in Q4 2022.
  • Median Operating Leases over the past 5 years was $1.7 million (2021), compared with a mean of $1.7 million.
  • Biggest five-year swings in Operating Leases: crashed 66.67% in 2022 and later skyrocketed 456.21% in 2023.
  • AVITA Medical's Operating Leases stood at $918000.0 in 2021, then crashed by 66.67% to $306000.0 in 2022, then skyrocketed by 456.21% to $1.7 million in 2023, then surged by 66.86% to $2.8 million in 2024, then dropped by 24.82% to $2.1 million in 2025.
  • The last three reported values for Operating Leases were $2.1 million (Q4 2025), $2.3 million (Q3 2025), and $2.4 million (Q2 2025) per Business Quant data.